688301.SHG iRay Technology Co Ltd
- Market cap
- CNY 24.9B
- P/E
- 31.9x
- P/B
- 2.89x
- ROE
- 9.5%
- Dividend yield
- 0.86%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 688301.SHG undervalued?
Graham number688301.SHG trades 102.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
iRay Technology Co Ltd fundamental analysis
No fundamental analysis for iRay Technology Co Ltd yet.
iRay Technology Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About iRay Technology Co Ltd
iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components and micro-display backplanes for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-ray sources; high voltage generators; radiation dete…
Full company profileiRay Technology Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
iRay Technology Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 256M | 356M | 439M | 546M | 784M | 1.19B | 1.55B | 1.86B | 1.83B | 2.30B | 3.33B |
| Gross Profit | 130M | 180M | 202M | 269M | 398M | 656M | 887M | 1.06B | 916M | 2.30B | 1.59B |
| Operating Income | 46.3M | 64.6M | 60.7M | 95.9M | 252M | 550M | 709M | 684M | 507M | 694M | 962M |
| EBITDA | 5.02M | 70.6M | 81.4M | 123M | 282M | 586M | 750M | 742M | 585M | 746M | 974M |
| Net Income | 42.8M | 54.3M | 60.6M | 96.4M | 222M | 484M | 641M | 607M | 465M | 661M | 763M |
| EPS | - | 0.37 | 0.41 | 0.65 | 1.37 | 2.43 | 3.21 | 2.99 | 2.24 | 3.30 | 2.44 |
| Balance Sheet | |||||||||||
| Total Assets | 261M | 381M | 492M | 698M | 2.90B | 3.54B | 5.82B | 7.51B | 9.08B | 12.8B | 13.3B |
| Total Liabilities | 83.1M | 130M | 161M | 272M | 262M | 461M | 1.92B | 3.16B | 4.44B | -6.07B | 4.83B |
| Shareholders' Equity | 178M | 251M | 330M | 426M | 2.63B | 3.05B | 3.88B | 4.33B | 4.64B | 6.07B | 8.02B |
| Cash & Short-term Investments | 114M | 84.0M | 100M | 136M | 2.34B | 2.26B | 3.37B | 2.15B | 2.21B | 3.41B | 3.35B |
| Total Debt | - | 4.69M | 9.91M | 58.1M | 73.7M | 59.6M | 1.43B | 2.10B | 3.54B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 40.1M | 102M | 19.3M | 30.8M | 262M | 248M | 317M | 340M | 360M | 1.30B | - |
| Capital Expenditure | 20.7M | 36.1M | 47.7M | 40.1M | 16.9M | 192M | 717M | 1.85B | 1.44B | 1.69B | 1.12B |
| Free Cash Flow | 19.4M | 65.6M | -28.4M | -9.28M | 245M | 56.3M | -401M | -1.51B | -1.08B | -384M | -138M |
| Ratios | |||||||||||
| ROE | 24.1% | 21.6% | 18.4% | 22.7% | 8.4% | 15.9% | 16.5% | 14.0% | 10.0% | 10.9% | 9.5% |
| ROA | 16.4% | 14.3% | 12.3% | 13.8% | 7.7% | 13.7% | 11.0% | 8.1% | 5.1% | 5.2% | 5.7% |
| Net Profit Margin | 16.7% | 15.3% | 13.8% | 17.7% | 28.3% | 40.8% | 41.4% | 32.6% | 25.4% | 28.8% | 22.9% |
| Debt to Equity | - | 0.02x | 0.03x | 0.14x | 0.03x | 0.02x | 0.37x | 0.48x | 0.76x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
iRay Technology Co Ltd dividends
- Dividend yield
- 0.86%
- Forward dividend
- 1.00 CNY
- Payout ratio
- 32.6%
- Ex-dividend date
- Jun 12, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 215M | 1.07 | 32.6% |
| 2024 | CNY 258M | 1.24 | 55.4% |
| 2023 | CNY 219M | 1.08 | 36.1% |
| 2022 | CNY 161M | 0.81 | 25.2% |
| 2021 | CNY 72.5M | 0.36 | 15.0% |
| 2020 | CNY 2.90M | 0.02 | 1.3% |
| 2019 | CNY 371K | 0.00 | 0.4% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jun 12, 2026.
Who owns iRay Technology Co Ltd
- Insiders 27.31%
- Institutions 23.95%
- Public & others 48.74%
- Shares outstanding 313M
- Free float 208M
iRay Technology Co Ltd company profile
- Company name
- iRay Technology Co Ltd
- Ticker
- 688301.SHG
- ISIN
- CNE1000042V8
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 2,292
- Fiscal year end
- December
- Address
- No.999, Huanqiao Road, Shanghai, China, 201315
- Phone
- 86 21 5072 0560
- Website
- iraygroup.com
About iRay Technology Co Ltd
iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components and micro-display backplanes for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-ray sources; high voltage generators; radiation detecting materials; software; and other products. It is also involved in the technology and product development; customer service; and investment and management activities. The company exports its products to approximately 80 countries. The company was formerly known as iRay Technology Company Limited and changed its name to iRay Group in February 2025. iRay Group was incorporated in 2011 and is headquartered in Shanghai, China.
iRay Technology Co Ltd management
10- Mr. Tieer GuChairman & GM · born 1968
- Ms. Yan JiangChief Financial Officer · born 1975
- Mr. Chengbin QiuCTO, Deputy GM, & Director · born 1964
- Mr. Guo Hua ZhangDeputy General Manager · born 1984
- Mr. Dong ZhaoDeputy General Manager · born 1964
- Mr. Xiaoyu DongDeputy General Manager · born 1978
- Mr. Yimin HuangDeputy GM & Core Technical Staff · born 1980
- Mr. Zhiqiang FangDeputy GM & Core Technician · born 1977
- Yuhan TongAccounting Supervisor
- Mr. Yancheng LinCore Technical Staff · born 1983